相关实验视频
Updated: Jun 11, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
43
罕见疾病:风湿病学家需要知道什么?
Renan Rodrigues Neves Ribeiro do Nascimento1, Daniela Gerent Petry Piotto1, Eutilia Andrade Medeiros Freire2
1Universidade Federal de Sao Paulo - Escola Paulista de Medicina, Rua Botucatu, 740, 3º andar, São Paulo, SP, 04023-062, Brazil.
Advances in rheumatology (London, England)
|September 28, 2024
概括
罕见疾病 (RD) 影响的人很少,而孤儿疾病 (OD) 被忽视. 了解这些区别对于风湿病学家来说至关重要,他们需要通过新的向疗法来管理复杂的自身免疫和自身炎症疾病.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 罕见疾病 罕见疾病
背景情况:
- 区分罕见疾病 (低患病率) 和孤儿疾病 (被忽视) 是非常重要的.
- 由于诊断能力的提高,罕见的类风湿病对类风湿病学家来说构成重大挑战.
- 对罕见的自身免疫和自身炎症性类风湿性疾病的兴趣日益增长,正在推动对免疫失调的理解.
研究的目的:
- 审查目前对罕见类风湿性疾病的理解.
- 突出风湿病学家在管理这些疾病中的关键作用.
- 讨论在罕见类风湿病领域的风湿病学家面临的未来挑战.
主要方法:
- 关于罕见的类风湿性疾病的文献综述.
- 分析了解自身免疫和自身炎症机制的最新进展.
- 探索针对罕见的类风湿性疾病的新兴向治疗方法.
主要成果:
- 在颗粒状,囊胞性和高氨酸性疾病中阐明免疫失调.
- 开发用于罕见的类风湿性疾病的创新向治疗方法.
- 承认罕见疾病的诊断能力不断扩大.
结论:
- 风湿病学家在为患有罕见风湿性疾病的患者提供医疗保健方面发挥着至关重要的作用.
- 了解疾病机制的进步正在导致新的治疗策略.
- 未来的挑战包括适应新的诊断工具和管理越来越多的罕见疾病.
相关概念视频
Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
Rheumatic Heart Disease IV: Nursing Management
5
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
5
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
8
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
8
Genome-wide Association Studies-GWAS
13.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.2K
Rheumatic Heart Disease I: Introduction
3
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
3
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K

